Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision

被引:59
作者
Soyka, Michael [1 ,2 ,3 ]
Kranzler, Henry R. [4 ,5 ]
Hesselbrock, Victor [6 ]
Kasper, Siegfried [7 ]
Mutschler, Jochen [1 ,8 ]
Moeller, Hans-Juergen [2 ]
机构
[1] Psychiat Hosp Meiringen, Meiringen, Switzerland
[2] Ludwig Maximilians Univ Munchen, Dept Psychiat, Munich, Germany
[3] Med Pk Chiemseeblick, Rasthausstr 25, D-83233 Bernau, Germany
[4] Univ Penn, Crescenz VAMC, Philadelphia, PA 19104 USA
[5] VISN 4 MIRECC, Philadelphia, PA USA
[6] Univ Connecticut Hlth, Farmington, CT USA
[7] Univ Vienna, Dept Psychiat Med, Vienna, Austria
[8] Univ Zurich, Psychiat Hosp, Zurich, Switzerland
关键词
Alcoholism; pharmacotherapy; acamprosate; baclofen; naltrexone; nalmefene; topiramate; carbamazepine; disulfiram; ondansetron; benzodiazepine; TRANSCRANIAL MAGNETIC STIMULATION; PSYCHIATRY WFSBP GUIDELINES; PLACEBO-CONTROLLED TRIAL; NATIONAL EPIDEMIOLOGIC SURVEY; DEEP BRAIN-STIMULATION; COGNITIVE-BEHAVIORAL TREATMENT; POSITRON-EMISSION-TOMOGRAPHY; INDUCED PSYCHOTIC DISORDER; GAMMA-HYDROXYBUTYRATE GHB; PITUITARY BETA-ENDORPHIN;
D O I
10.1080/15622975.2016.1246752
中图分类号
R749 [精神病学];
学科分类号
100204 [神经病学];
摘要
These practice guidelines for the biological treatment of alcohol use disorders are an update of the first edition, published in 2008, which was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). For this 2016 revision, we performed a systematic review (MEDLINE/PUBMED database, Cochrane Library) of all available publications pertaining to the biological treatment of alcoholism and extracted data from national guidelines. The Task Force evaluated the identified literature with respect to the strength of evidence for the efficacy of each medication and subsequently categorised it into six levels of evidence (A-F) and five levels of recommendation (1-5). Thus, the current guidelines provide a clinically and scientifically relevant, evidence-based update of our earlier recommendations. These guidelines are intended for use by clinicians and practitioners who evaluate and treat people with alcohol use disorders and are primarily concerned with the biological treatment of adults with such disorders.
引用
收藏
页码:86 / 119
页数:34
相关论文
共 358 条
[91]
The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia [J].
Drake, RE ;
Xie, HY ;
McHugo, GJ ;
Green, AI .
SCHIZOPHRENIA BULLETIN, 2000, 26 (02) :441-449
[92]
Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats [J].
Economidou, D ;
Mattioli, L ;
Cifani, C ;
Perfumi, M ;
Massi, M ;
Cuomo, V ;
Trabace, L ;
Ciccocioppo, R .
PSYCHOPHARMACOLOGY, 2006, 183 (04) :394-403
[93]
Variations in GABRA2, encoding the α2 subunit of the GABAA receptor, are associated with alcohol dependence and with brain oscillations [J].
Edenberg, HJ ;
Dick, DM ;
Xuei, XL ;
Tian, HJ ;
Almasy, L ;
Bauer, LO ;
Crowe, RR ;
Goate, A ;
Hesselbrock, V ;
Jones, K ;
Kwon, J ;
Li, TK ;
Nurnberger, JI ;
O'Connor, SJ ;
Reich, T ;
Rice, J ;
Schuckit, MA ;
Porjesz, B ;
Foroud, T ;
Begleiter, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 74 (04) :705-714
[94]
Varenicline in the Treatment of Alcohol Use Disorders [J].
Erwin, Beth L. ;
Slaton, Rachel M. .
ANNALS OF PHARMACOTHERAPY, 2014, 48 (11) :1445-1455
[95]
Carbamazepine and Valproate as Adjuncts in the Treatment of Alcohol Withdrawal Syndrome: A Retrospective Cohort Study [J].
Eyer, Florian ;
Schreckenberg, Meike ;
Hecht, Daniela ;
Adorjan, Krisztina ;
Schuster, Tibor ;
Felgenhauer, Norbert ;
Pfab, Rudi ;
Strubel, Tim ;
Zilker, Thomas .
ALCOHOL AND ALCOHOLISM, 2011, 46 (02) :177-184
[96]
Topiramate (topamax) reduces conditioned abstinence behaviours and handling-induced convulsions (HIC) after chronic administration of alcohol in Swiss-Webster mice [J].
Farook, Justin M. ;
Morrell, Dennis J. ;
Lewis, Ben ;
Littleton, John M. ;
Barron, Susan .
ALCOHOL AND ALCOHOLISM, 2007, 42 (04) :296-300
[97]
Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: A single centres' experience with pharmacotherapy [J].
Feeney, GFX ;
Connor, JP ;
Young, RM ;
Tucker, J ;
McPherson, A .
ALCOHOL AND ALCOHOLISM, 2006, 41 (03) :321-327
[98]
Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis [J].
Fehr, C ;
Sander, T ;
Tadic, A ;
Lenzen, KP ;
Anghelescu, I ;
Klawe, C ;
Dahmen, N ;
Schmidt, LG ;
Szegedi, A .
PSYCHIATRIC GENETICS, 2006, 16 (01) :9-17
[99]
Alcoholics Anonymous and other 12-step programmes for alcohol dependence [J].
Ferri, M. ;
Amato, L. ;
Davoli, M. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (03)
[100]
Depression outcome in alcohol dependent patients: An evaluation of the role of independent and substance-induced depression and other predictors [J].
Foulds, James A. ;
Sellman, J. Douglas ;
Adamson, Simon J. ;
Roden, Joseph M. ;
Mulder, Roger T. ;
Joyce, Peter R. .
JOURNAL OF AFFECTIVE DISORDERS, 2015, 174 :503-510